The observation that EGFR or mTORC1 activation promotes GBM cell death under hypoxic and partially glucose-deprived conditions, whereas PI3K/mTOR inhibition can prevent such cell death, supports this notion. The gene discussed is MTOR; the disease is glioblastoma.